Aleš Ryška

Aleš Ryška (born 16 February 1972) is a retired Czech football defender. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Aleš Ryška', query time: 0.02s Refine Results
  1. 1
    Histopathological spectrum of common aldosterone-driver gene mutations in aldosterone-producing adenomas

    Histopathological spectrum of common aldosterone-driver gene mutations in aldosterone-producing adenomas by Fatin Athirah Pauzi, Muaatamarulain Mustangin, Geok Chin Tan, Ales Ryska, Jiri Ceral, Miroslav Solar, Elena Aisha Azizan

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Molecular predictive biomarker testing in advanced thyroid cancer – a European consensus

    Molecular predictive biomarker testing in advanced thyroid cancer – a European consensus by Aleš Ryška, Jaume Capdevila, Matthias S Dettmer, Rossella Elisei, Dagmar Führer, Julien Hadoux, Barbara Jarząb, Laura D Locati, Kate Newbold, Giovanni Tallini, Silvia Uccella, Lori Wirth, Ravinder Singh, Iris M Simon, Pilar Camacho, Laura Fugazzola

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy

    Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy by Ondrej Fiala, Milos Pesek, Jana Skrickova, Vitezslav Kolek, Frantisek Salajka, Marcela Tomiskova, Monika Satankova, Juraj Kultan, Jana Kuliskova, Martin Svaton, Michal Hrnciarik, Karel Hejduk, Renata Chloupkova, Ondrej Topolcan, Helena Hornychova, Marketa Nova, Ales Ryska, Jindrich Finek

    Published 2017-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer

    M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer by Vladimir Benes, Ladislav Pecen, Jelena Pistolic, Lorenzo Galluzzi, Iva Truxova, Radek Špíšek, Lenka Kasikova, Michal Hensler, Petr Skapa, Jan Laco, Ivan Praznovec, Tomas Brtnicky, Lukas Rob, Catherine Sautes-Fridman, Ales Ryska, Jitka Fucikova, Wolf Herve Fridman, Vít Drochýtek, Sarka Vosahlikova, Karel Fiser, Jana Rakova, Tereza Lanickova, Irena Moserova, Martina Rehackova, Ludek Sojka

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing

    Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing by Umberto Malapelle, Chien‐Chin Chen, Enrique deÁlava, Paul Hofman, Daniel Kazdal, Tae‐Jung Kim, Tony Kiat Hon Lim, Aleš Ryška, Angelica A Saetta, Ed Schuuring, Giancarlo Troncone, Michele Biscuola, Yi‐Lin Chen, Gek San Tan, Charles Hugo Marquette, Maria Michelli, Arja terElst, Hana Vošmiková, Joshua Kapp, Sebastian Gonzalez‐McQuire, Andromachi Giannopoulou, Jean Marie Franzini, Victoria Lucia Rabsiun Aramburu, Anna Baggi, Albrecht Stenzinger

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: